Measuring cardiac cTnI at the patient’s bedside as an aid in the diagnosis of myocardial infarction (MI) Circulatory System Myocardial infarction (MI)
Conditions
Interventions
Patient blood will be tested on the POC device and the result compared to local Troponin Lab test results. The study does not interfere with routine patient treatment and does not alter the routine di
Sponsors
Philips Electronics Nederland, B.V. - HandHeld Diagnostics
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. = 18 years old 2. Patients presenting with symptoms suggestive of ACS, at ER or CCU 3. Patients presenting for the 1st time after onset of symptoms 4. Onset of last episode of symptoms suggestive of AMI <12 hrs prior to presentation 5. Signed informed consent form
Exclusion criteria
Exclusion criteria: 1. Patients already admitted for the same set of symptoms at a previous healthcare institution before being transferred to the participating clinical site 2. Patients requiring emergency treatment (respiratory or cardiovascular support, arrhythmia control, coronary reperfusion) 3. Cognitive impairment or inability to understand study information 4. Unwilling or unable to provide written consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| For individual patients, blood samples will be tested on the POC device from up to three time points (t=0, t=2-4 hours and t = 6-24 hours). Each result is a quantitative TnI measurement which can be compared to results generated by the local Lab equipment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Users (nurses) will be observed and interviewed to gather user feedback on the use of the system. Data regarding the hospital workflow for MI patients will be gathered to allow determining whether workflow efficiency can potentially be improved with the introduction of POC testing. | — |
Countries
Austria, France, Germany, Netherlands, United Kingdom
Contacts
Public ContactHenk Peels
Outcome results
None listed